Presentation is loading. Please wait.

Presentation is loading. Please wait.

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness.

Similar presentations


Presentation on theme: "Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness."— Presentation transcript:

1 Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis  John F. Forbes, PhD, Donald J. Adam, MD, FRCSEd, Jocelyn Bell, PhD, F. Gerry R. Fowkes, PhD, FRCPE, Ian Gillespie, MD, FRCR, Gillian M. Raab, PhD, Charles Vaughan Ruckley, ChM, FRCSEd, CBE, Andrew W. Bradbury, BSc, MD, MBA, FRCSEd  Journal of Vascular Surgery  Volume 51, Issue 5, Pages 43S-51S (May 2010) DOI: /j.jvs Copyright © 2010 Society for Vascular Surgery Terms and Conditions

2 Fig 1 EuroQol-5D scores, up to 36 months after randomization at baseline, are based on multiple imputation of missing information. CI, Confidence interval. Journal of Vascular Surgery  , 43S-51SDOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Joint density of incremental cost and incremental quality adjusted life-year (QALY) of surgery compared with angioplasty. Positive (negative) incremental costs show that surgery is more (less) costly than angioplasty. Positive (negative) incremental QALYs show that surgery is more (less) effective than angioplasty. Journal of Vascular Surgery  , 43S-51SDOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions


Download ppt "Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness."

Similar presentations


Ads by Google